Literature DB >> 25375026

Structures and bioactivities of dihydrochalcones from Metrodorea stipularis.

Marcela C de Melo Burger1, João Batista Fernandes, Maria F das Graças Fernandes da Silva, Aster Escalante, Jacques Prudhomme, Karine G Le Roch, Mario A Izidoro, Paulo C Vieira.   

Abstract

Metrodorea stipularis stem extracts were studied in the search for possible antichagastic, antimalarial, and antitumoral compounds using cruzain from Trypanosoma cruzi, Plasmodium falciparum, and cathepsins B and L, as molecular targets, respectively. Dihydrochalcones 1, 2, 3, and 4 showed significant inhibitory activity against all the targets. Compounds 1-4 displayed IC50 values ranging from 7.7 to 21.6 μM against cruzain; dihydrochalcones 2 and 4 inhibited the growth of three different strains of P. falciparum in low micromolar concentrations; and against cathepsins B and L these compounds presented good inhibitory activity with IC50 values ranging from 1.0 to 14.9 μM. The dihydrochalcones showed good selectivity in their inhibitory activities against the cysteine proteases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25375026      PMCID: PMC7138024          DOI: 10.1021/np500453x

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  13 in total

1.  A new dimeric dihydrochalcone and a new prenylated flavone from the bud covers of Artocarpus altilis: potent inhibitors of cathepsin K.

Authors:  Ashok D Patil; Alan J Freyer; Lew Killmer; Priscilla Offen; Paul B Taylor; Bartholomew J Votta; Randall K Johnson
Journal:  J Nat Prod       Date:  2002-04       Impact factor: 4.050

2.  Parasitology. Drugs to combat tropical protozoan parasites.

Authors:  Michael H Gelb; Wim G J Hol
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

Review 3.  Emerging roles of cysteine cathepsins in disease and their potential as drug targets.

Authors:  Olga Vasiljeva; Thomas Reinheckel; Christoph Peters; Dusan Turk; Vito Turk; Boris Turk
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

Review 4.  The value of natural products to future pharmaceutical discovery.

Authors:  Dwight D Baker; Min Chu; Uma Oza; Vineet Rajgarhia
Journal:  Nat Prod Rep       Date:  2007-05-09       Impact factor: 13.423

Review 5.  Cruzain : the path from target validation to the clinic.

Authors:  Mohammed Sajid; Stephanie A Robertson; Linda S Brinen; James H McKerrow
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

6.  Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy.

Authors:  Tyler N Bennett; Michelle Paguio; Bojana Gligorijevic; Clement Seudieu; Andrew D Kosar; Eugene Davidson; Paul D Roepe
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

7.  Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening.

Authors:  Martin Smilkstein; Nongluk Sriwilaijaroen; Jane Xu Kelly; Prapon Wilairat; Michael Riscoe
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

8.  Dihydrochalcones and coumarins of Esenbeckia grandiflora subsp. brevipetiolata.

Authors:  M Trani; A Carbonetti; G Delle Monache; F Delle Monache
Journal:  Fitoterapia       Date:  2004-01       Impact factor: 2.882

9.  Discovery of gene function by expression profiling of the malaria parasite life cycle.

Authors:  Karine G Le Roch; Yingyao Zhou; Peter L Blair; Muni Grainger; J Kathleen Moch; J David Haynes; Patricia De La Vega; Anthony A Holder; Serge Batalov; Daniel J Carucci; Elizabeth A Winzeler
Journal:  Science       Date:  2003-07-31       Impact factor: 47.728

10.  Marine actinomycetes: a new source of compounds against the human malaria parasite.

Authors:  Jacques Prudhomme; Eric McDaniel; Nadia Ponts; Stéphane Bertani; William Fenical; Paul Jensen; Karine Le Roch
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240

View more
  5 in total

1.  Development of a pharmacophore for cruzain using oxadiazoles as virtual molecular probes: quantitative structure-activity relationship studies.

Authors:  Anacleto S de Souza; Marcelo T de Oliveira; Adriano D Andricopulo
Journal:  J Comput Aided Mol Des       Date:  2017-08-09       Impact factor: 3.686

2.  Novel Non-Peptide Inhibitors against SmCL1 of Schistosoma mansoni: In Silico Elucidation, Implications and Evaluation via Knowledge Based Drug Discovery.

Authors:  Atif Zafar; Sabahuddin Ahmad; Asim Rizvi; Masood Ahmad
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

Review 3.  Flavonoids from Brazilian Cerrado: Biosynthesis, Chemical and Biological Profile.

Authors:  Josana de Castro Peixoto; Bruno Junior Neves; Flávia Gonçalves Vasconcelos; Hamilton Barbosa Napolitano; Maria Gonçalves da Silva Barbalho; Sandro Dutra E Silva; Lucimar Pinheiro Rosseto
Journal:  Molecules       Date:  2019-08-09       Impact factor: 4.411

4.  Identification of Chalcones as Fasciola hepatica Cathepsin L Inhibitors Using a Comprehensive Experimental and Computational Approach.

Authors:  Florencia Ferraro; Alicia Merlino; Nicolás Dell Oca; Jorge Gil; José F Tort; Mercedes Gonzalez; Hugo Cerecetto; Mauricio Cabrera; Ileana Corvo
Journal:  PLoS Negl Trop Dis       Date:  2016-07-27

5.  Identification of Interleukin-8-Reducing Lead Compounds Based on SAR Studies on Dihydrochalcone-Related Compounds in Human Gingival Fibroblasts (HGF-1 cells) In Vitro.

Authors:  Katharina Schueller; Joachim Hans; Stefanie Pfeiffer; Jessica Walker; Jakob P Ley; Veronika Somoza
Journal:  Molecules       Date:  2020-03-18       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.